Results for tag: "Congenital Adrenal Hyperplasia"

Congenital Adrenal Hyperplasia (CAH) is a group of inherited disorders that affect the adrenal glands. It is caused by a deficiency in the enzymes that produce cortisol and aldosterone, hormones that regulate the body's metabolism and response to stress. Symptoms of CAH can include early puberty, abnormal genitalia, and salt wasting. Treatment typically involves hormone replacement therapy and, in some cases, surgery. The CAH market is a subset of the larger endocrinology market, which includes treatments for a variety of endocrine disorders. The CAH market is expected to grow due to increasing awareness of the condition and the availability of new treatments. Some companies in the CAH market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more